Condiciones de salud que gardenia puede ayudar a apoyar.
Crocin, geniposide, and genipin from Gardenia jasminoides are well-characterized antioxidants. They scavenge hydroxyl radicals, boost superoxide dismutase (SOD) and catalase (CAT) activity, reduce malondialdehyde (MDA), and raise glutathione (GSH) in multiple organ systems. Antioxidant activity has been confirmed in cell-based assays, animal models, and is recognized in pharmacological reviews.
Gardenia fruit (Fructus Gardeniae) and its constituent geniposide show anxiolytic activity in preclinical models. The classical Kampo formula kamishoyosan, which contains Gardenia jasminoides, has been studied clinically and found to ease anxiety in menopausal women comparably to paroxetine. The Zhi Zi Chi decoction, a Gardenia-based TCM formula, modulates the gut–brain axis to reduce anxiety-like behavior in stress models.
Geniposide and genipin from Gardenia jasminoides have documented antiplatelet aggregation and antithrombotic activities in animal models. Aqueous extract of G. jasminoides significantly inhibited arterial thrombosis in animal models, and geniposide inhibited platelet aggregation in earlier in vitro studies.
Gardenia jasminoides extract has anti-hypertensive effects demonstrated in an L-NNA-induced hypertension mouse model, attributed primarily to geniposide. Treated mice showed significantly lower systolic, diastolic, and mean blood pressure than controls. Traditional use of Zhizi for hypertension is also well-documented.
Geniposide and genipin from Gardenia jasminoides have well-documented hypoglycemic activity in multiple animal models of type 2 diabetes. Geniposide inhibits hepatic glucose-6-phosphatase and glycogen phosphorylase to reduce glucose output, and genipin inhibits UCP2 to restore pancreatic beta-cell insulin secretion. Human use in China for diabetes management has historical grounding in the Chinese Pharmacopoeia.
Inhaled volatiles of Gardenia jasminoides, rich in terpenes and linalool, measurably reduce physiological stress markers. A 2025 human study found gardenia aroma decreased blood pressure, beta-wave power, and skin electrical signals while raising alpha-wave power—objective indicators of relaxation—in college-student volunteers. The plant's sedative properties are well-recognized in traditional and Kampo medicine.
Gardenia jasminoides extract reduces total cholesterol and hepatic cholesterol in HFD rodent models. Crocin inhibits pancreatic lipase to reduce lipid absorption. Geniposide improves lipid profiles including LDL-C and HDL-C in T2DM models. Cholesterol reduction is a documented pharmacological property of gardenia in multiple reviews.
Genipin and geniposide from Gardenia jasminoides demonstrate broad-spectrum anti-inflammatory activity across multiple preclinical models. They suppress NF-κB, MAPK, and AP-1 signaling, reduce pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), and inhibit nitric oxide production. These findings span carrageenan edema models, LPS-induced macrophage assays, and in vivo lung injury models.
Geniposide has documented analgesic properties, and GFE dose-dependently inhibited acetic acid-induced abdominal writhing in mice—a standard preclinical pain model. Genipin is a specific hydroxyl radical scavenger with both analgesic and anti-inflammatory activities. Analgesic/antipyretic use is recognized in the Chinese, Japanese, and Korean Pharmacopeias.
Gardeniae Fructus is prescribed in TCM for brain aging and age-related diseases, and is supported by preclinical evidence for neuroprotection in Alzheimer's and Parkinson's disease models. Geniposide, genipin, and crocin demonstrate activities addressing mitochondrial dysfunction, oxidative stress, apoptosis, and neuroinflammation relevant to cognitive aging.
Gardenia jasminoides fruit extract (GFE) and its constituent geniposide have demonstrated protective effects in multiple rat models of ulcerative colitis (TNBS- and DSS-induced). GFE significantly reduced disease activity index scores, histological damage, and pro-inflammatory cytokines while increasing antioxidant capacity. Geniposide's mechanism involves KEAP1-Nrf2 pathway activation and barrier function restoration.
Geniposide and related iridoids from Gardenia jasminoides exhibit antidepressant-like effects in rodent models via HPA axis normalization and neuroprotective mechanisms. Kampo formulas containing gardenia showed antidepressant effects comparable to paroxetine in menopausal women. A 2023 meta-analysis found TCM formulas with Gardenia Fructus significantly reduced Hamilton Depression Scale scores versus no treatment.
Gardenia jasminoides extract ameliorates atopic dermatitis in preclinical models by restoring skin barrier function and suppressing Th2-mediated immune overactivation. Genipin inhibits T cell activation via ORAI1 channel modulation, reducing allergic inflammation. These findings support a mechanistic basis for gardenia's traditional use in inflammatory skin conditions.
Gardenia jasminoides extract has been shown to improve atopic dermatitis symptoms in mouse models by restoring skin barrier function and modulating T helper 2-mediated immune responses. Topical 70% ethanolic GF extract reduces AD symptoms in dust-mite-sensitized animals. Genipin's suppression of T cell activation provides an immunological basis for this activity.
Gardenia jasminoides has documented cholagogue (bile-promoting) effects and is traditionally used for jaundice and gallbladder-related liver conditions. Modern pharmacological studies confirm that Gardeniae Fructus has hepatoprotective and cholagogic effects and regulates bile acid enterohepatic circulation. Geniposide is listed in the Chinese Pharmacopoeia as an indicator compound for this use.
Gardenia jasminoides extract has been studied for protective effects in gastritis models, including H. pylori-associated gastritis and NSAID-induced gastropathy. Geniposide and genipin reduce CagA, VacA, IL-8, IFN-γ, and IL-1β in H. pylori-infected models. GFE protects gastric mucosa by upregulating PGE2 and MUC5AC and downregulating iNOS and NF-κB.
Geniposide from Gardenia jasminoides has been shown to inhibit body weight gain and improve lipid and glucose markers in obese animal models. A human study of middle-aged obese women incorporating gardenia fruit observed changes in body composition and metabolic hormones. Genipin promotes fat oxidation via PPAR-α and reverses obesity-induced beta-cell dysfunction.
Fructus Gardeniae has documented sedative activity and is used in TCM and Kampo formulas for insomnia and sleep disturbance. Animal research shows Gardenia jasminoides extract ameliorates sleep-deprivation-induced anxiety and behavioral deficits via hippocampal metabolomics and gut microbiota modulation. The Kampo formula kamishoyosan, containing gardenia, is specifically indicated for insomnia.
Geniposide and genipin from Gardenia jasminoides improve insulin sensitivity through PPAR-γ and PPAR-α activation and UCP2 inhibition. A pilot clinical study showed geniposide reduced insulin resistance and liver fibrosis markers in NAFLD patients. GJ aqueous extract improved insulin sensitivity in steroid-induced insulin-resistant rats.
Gardenia jasminoides has extensive preclinical and some clinical evidence for hepatoprotective activity. A clinical study demonstrated that crude gardenia extract rapidly lowers serum bilirubin and transaminase levels in jaundice-induced acute hepatitis. Geniposide protects against liver injury from acetaminophen, CCl4, alcohol, ischemia-reperfusion, sepsis, and cholestasis, via anti-inflammatory and antioxidant mechanisms.
Gardenia jasminoides extracts rescued memory loss in a Drosophila Alzheimer's disease model overexpressing Aβ protein. Geniposide shows neuroprotective effects in rodent models of Alzheimer's and Parkinson's disease relevant to cognitive decline. Gardeniae Fructus is prescribed in TCM for brain aging and age-related cognitive conditions.
Gardenia jasminoides extract addresses multiple components of metabolic syndrome—including hyperglycemia, insulin resistance, dyslipidemia, hypertension, and hepatic steatosis—in rodent models. A 2024 PMC study showed GJ extract attenuated high-fat-diet-induced glycolipid metabolism disorder by targeting gut microbiota and TLR4/Myd88/NF-κB pathway.
Gardenia jasminoides has been directly tested in a cerulein-induced acute pancreatitis mouse model, demonstrating protective effects including reduced pancreatic weight/body weight ratio, lower serum amylase and lipase, and suppressed pro-inflammatory mediators TNF-α, IL-1β, and IL-6. Geniposide also protects pancreatic beta-cells from oxidative stress damage in diabetes models.
A double-blind placebo-controlled clinical trial in 40 female volunteers found that a Gardenia jasminoides fruit extract formulated in Natural Deep Eutectic Solvent (NaDES) reduced signs of skin aging and protected against digital-stress-induced premature aging. The extract acts as a blue-light filter and via crocin/crocetin melatonin-like MT1 receptor binding.
Gardenia jasminoides volatiles demonstrably reduce physiological stress markers in human volunteers. The Zhi Zi Chi decoction modulates HPA axis stress responses in rodent models. Geniposide normalizes elevated corticosterone and ACTH in chronic stress-exposed rats. These effects are consistent with gardenia's long traditional classification as a calming herb.
Geniposide and crocin from Gardenia jasminoides lower serum and hepatic triglycerides in multiple animal models. Geniposide improved serum triglyceride levels in high-sugar-diet rats, while crocin inhibits pancreatic lipase to reduce dietary fat absorption. Gardenia extract reduced hepatic triglyceride content in HFD mice.
Gardenia jasminoides extract has been shown in preclinical studies to protect against NSAID-induced gastric ulcers by increasing mucosal protective factors (PGE2, MUC5AC) and suppressing iNOS and NF-κB. Genipin inhibits gastric lesion formation, and the combination with H. pylori gastroprotection provides a multi-mechanism anti-ulcer profile.
TCM uses Zhizi (Gardenia jasminoides) to treat abdominal pain, gastrointestinal disturbance, and 'heat and dampness' in the digestive tract. It appears in the Shennong Herbal as an antiphlogistic agent for gastrointestinal conditions. Geniposide demonstrates purgative and gastroprotective activities in pharmacological studies.
Treating fever is one of the oldest and most consistently documented traditional uses of Gardenia jasminoides (Zhizi) in TCM, Kampo, and Korean traditional medicine. It is recorded in the Shennong Herbal (Dong Han dynasty, ~25–220 AD) and Chinese Pharmacopoeia for clearing heat and reducing fever. Geniposide has antipyretic properties in pharmacological frameworks, though formal clinical antipyretic trials are absent.
Headache is one of the classically documented traditional uses of Gardenia jasminoides in TCM, folk medicine, and Ayurvedic traditions. It appears consistently across historical texts and pharmacopeial references as an application of Zhizi. No controlled clinical trials examining gardenia for headache as an isolated intervention have been identified.
Rashes and hives are documented traditional uses of Gardenia jasminoides in TCM, where Zhizi is used for skin conditions characterized by heat and blood-heat pattern, presenting as red rashes, urticaria, or hives. Traditional topical and oral applications for inflammatory skin eruptions are well-recorded. Genipin and geniposide's anti-inflammatory and immunomodulatory properties provide mechanistic plausibility.
Topical application of Gardenia jasminoides for wound healing, sprains, and skin trauma has a well-documented history in TCM and Ayurvedic medicine. Modern sources note it is applied to the skin for bleeding, wound healing, sprains, and muscle soreness. Preclinical anti-inflammatory and antioxidant properties support a plausible mechanism, though clinical wound-healing trials are absent.
Volver